Sold as Mpi Dtpa Kit - Chelate, Technetium TC-99M Pentetate, An-Dtpa, Draximage Dtpa. Every FDA application for this active ingredient: 4 branded and 1 generic.
As of Nov 16, 2026, FDA lists 5 applications for Technetium TC-99M Pentetate Kit (sold as Mpi Dtpa Kit - Chelate, Technetium TC-99M Pentetate, An-Dtpa and others), first approved Feb 14, 1974, with 1 new use approved and 0 published complete response letters.
| Feb 14, 1974 | Technetium TC-99M PentetateNDA 17264 · New formulation or manufacturer | Ge Healthcare | 14 | Discontinued |
| Apr 15, 1976 | Mpi Dtpa Kit - ChelateNDA 17255 · New formulation or manufacturer | Ge Healthcare | 0 | Discontinued |
| Nov 16, 1976 | An-DtpaNDA 17714 · New formulation or manufacturer | Jubilant Draximage | 14 | Discontinued |
| Dec 29, 1989 | Draximage DtpaNDA 18511 · New formulation or manufacturer | Jubilant | 15 | Marketed |
| Mar 26, 2025 | Technetium TC-99M PentetateANDA 215146 | Curium | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA